Sign in

NCT06403631Completed

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis

Supporting Mental Health in Daily Life After the Diagnosis of Multiple Sclerosis: the Role of Flow Experience and Mindfulness

Source: ClinicalTrials.gov · Last updated 23 Apr 2026

Brief summary (registry, in English)

The overall goal of this observational study is to learn about the psychological resources of mindfulness and flow experience available to persons newly diagnosed with multiple sclerosis (MS). The primary study aim will be to analyze the relation of flow and mindfulness with mental health among individuals who received an MS diagnosis within the last year. Secondary aims will be to analyze the daily activities preferentially associated with flow, and to evaluate possible changes in daily flow retrieval. Participants will answer questionnaires measuring flow, mindfulness, positive mental health, anxiety and depression at project start and 6 months later.

Status (registry)
Completed
Study type
Observational
Enrollment
361 (actual)
First submitted
25 Apr 2024
Start date
6 Nov 2023
Primary completion date
25 Dec 2025
Lead sponsor
Marta Bassi
NCT number
NCT06403631

What you commit to

  • Study type: Observational
  • Participants enrolled: 361
  • From 6 Nov 2023 to the primary completion date, 25 Dec 2025
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • current or previous attendance in Mindfulness Based Interventions or Acceptance and Commitment Therapy

Other illness

  • neurological disorders other than MS
  • psychiatric disorders
  • severe physical impairment (EDSS=\>8)
  • severe cognitive impairment in comprehension, attention and execution of inferential-logical operations which could interfere with the ability to fill in questionnaires (equivalent scores 0-1 at Progressive Raven Matrices; score \<11.3 at the visual comprehension of sentences subtest of the Aphasia Neuropsychological Test; score \<37.9 at Symbol Digit Modalities Test; and score \<93.1 at the Brief Test of Intelligence)

Other

  • pregnancy

Who the study is looking for

  • age 18-50
  • clinically-definite MS diagnosed (with McDonald's revised criteria) within the previous 12 months
  • steroid treatment for at least 1 month
  • written informed consent

Age in the registry: 18 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Bari
Coordinator of this site? Confirm its status
BariItalyUnknown status
University of Cagliari
Coordinator of this site? Confirm its status
CagliariItalyUnknown status
University of Catania
Coordinator of this site? Confirm its status
CataniaItalyUnknown status
Azienda Ospedaliera Sant'Anna
Coordinator of this site? Confirm its status
ComoItalyUnknown status
University of Florence
Coordinator of this site? Confirm its status
FlorenceItalyUnknown status
Università Vita-Salute San Raffaele
Coordinator of this site? Confirm its status
MilanItalyUnknown status
San Luigi Gonzaga Hospital
Coordinator of this site? Confirm its status
OrbassanoItalyUnknown status
Azienda Ospedaliera San Camillo Forlanini
Coordinator of this site? Confirm its status
RomaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.